ANDOVER, Mass.--(BUSINESS WIRE)--Royal Philips Electronics (NYSE: PHG; AEX: PHI) today announced the commercial release of Philips EP cockpit to support clinicians and staff in the treatment of cardiac rhythm disorders, including complex ablation therapies. This new concept in electrophysiology (EP) labs combines Philips proven Allura Xper interventional lab with a number of innovative instruments to help make EP labs more convenient and efficient by creating a more intuitive EP lab working environment and integrating data management across the EP care cycle.
